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Physics, and Biophysics Graduate Program, The Ohio State University, Columbus, OhioABSTRACT Natural killer (NK) cells extend important immune resistance in vertebrates by lysing infected and tumor cells.
A fine balance between opposing signals generated by a diverse set of stimulatory and inhibitory NK-cell receptors determines
the fate of target cells interacting with the NK cells. We have developed a mathematical model involving membrane proximal
initial signaling events that provides novel mechanistic insights into how activation of NK cells is modulated by the half-life of
receptor-ligand interaction and ligand concentrations. We show that strong stimulatory ligands produce digital activation,
whereas weaker stimulatory ligands can mediate inhibition by strengthening the signals generated by inhibitory ligands, as indi-
cated in experiments in knockout mice. We find under certain conditions, counterintuitively, inhibitory receptors can help
mediate activation instead of inhibition. Mechanistic insights gained from NK-cell signaling can facilitate understanding of
complex signaling responses that occur due to cross talk between dueling signaling pathways in other cell types.INTRODUCTIONNatural killer (NK) cells are key players in our innate immu-
nity and constitute ~15% of our peripheral blood lympho-
cytes. NK cells scan the local environment with a diverse
set of germ-line-coded stimulatory and inhibitory receptors
(1) and are marked by their intrinsic ability to lyse infected
or tumor cells without any previous history of activation (1).
A subtle dynamic balance between the signals generated by
the receptors determines whether interactions between the
receptors and extracellular ligands will produce stimulatory
responses. Stimulated NK cells not only secrete cytotoxic
granules to lyse target cells (1), but can also create an
appropriate cytokine milieu to affect the ensuing adaptive
immune response (2,3). The central dogma behind NK-cell
tolerance toward healthy cells is the so-called missing-self
hypothesis (1,4), which asserts that every NK cell should
possess at least one inhibitory receptor that interacts with
self-inhibitory ligands (major histocompatibility complex
(MHC) class I molecules) expressed in healthy cells.
According to this hypothesis, healthy cells expressing
ligands for both stimulatory and inhibitory NK-cell recep-
tors delicately balance the dueling signals generated from
receptors and induce tolerance, unlike tumor and infected
cells, which downregulate inhibitory ligands or upregulate
stimulatory ligands to tip the balance in favor of activation.
The missing-self hypothesis has been challenged by
recent experiments (5,6), and a mechanistic understanding
of the competition between stimulatory and inhibitory
signals generated from a variety of receptors expressed at
the surface of NK cells interacting with target cells is
lacking (7–10). This creates a major roadblock to the
development of immune-based therapies whose aim is toSubmitted July 30, 2009, and accepted for publication July 22, 2010.
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standing of conflicting experimental results pertaining to
NK-cell development, activation, and tolerance.
The following problems make it difficult to understand
the system from a mechanistic perspective, even when
many of the signaling pathways responsible for NK-cell
activation are known:
1. NK-cell receptors are acquired in a stochastic manner in
the bonemarrow (11). Thus, NK cells possess a repertoire
of stimulatory and inhibitory receptors (11,12) whose
type and copy number vary from cell to cell. Further-
more, expression levels of ligands for different NK
receptors in healthy or tumor cells also vary at the
single-cell level. In addition to the variations in number
and type of receptors and their cognate ligands, the
strength of interactions between ligand receptor pairs
can be quite diverse. For example, the stimulatory mouse
receptor, NKG2D, binds to different ligands with a 100-
fold change in affinity (13), and the inhibitory mouse
receptor, Ly49A, binds to the MHC class I molecule,
H-2Dd, with a strong micromolar-range affinity but
barely interacts with the MHC class I ligand, H-2Kd
(14). Therefore, any decision about NK-cell activation
or tolerance has to be robust, but at the same time sensi-
tive, across these variations.
2. The initial interactions between the NK receptors and
their cognate ligands are propagated farther into the
cytosol by a series of signaling events involving protein
tyrosine kinases and adaptor and scaffold proteins
(8,10). Most of the signaling events are essentially
nonlinear kinetic processes, some of which could be
significantly affected by the fluctuations in copy number
of signaling molecules due to the stochastic nature
of biochemical reactions (15,16). It is difficult todoi: 10.1016/j.bpj.2010.07.061
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tolerance) response of NK cells that arises from an inte-
gration of signals mediated through these stochastic
nonlinear processes and fluctuations based on a combina-
tion of experimental observations and linear logical
reasoning alone.
Therefore, investigation of the kinetics of signal propaga-
tion involving the above variations in receptor and ligand
repertoire in presence of the nonlinearities and biochemical
stochastic fluctuations in the biochemical signaling
processes is a necessary first step toward understanding
the system mechanistically.
We have constructed a detailed molecular model that
addresses these problems. The model shows how stimula-
tory receptors can mediate activation or inhibition depend-
ing on the binding affinity of cognate stimulatory ligands.
We also characterize strengths of stimulatory and inhibitory
signals in terms of the microscopic parameters in the model
and show how balancing those signals can produce activa-
tion or tolerance in NK cells. The priming of NK cells,
measured as activation of Vav or Erk protein molecules in
the model, can possess a sharp activation threshold arising
from the enzymatic activation and deactivation of Vav
molecules. Activation of Vav and Erk molecules mediate
cytotoxicity by mobilizing and redistributing cytolytic gran-
ules and serine proteases at the contact zone of NK cells and
target cells (17). Lysis of target cells with upregulated stim-
ulatory ligands or downregulated inhibitory ligands by NK
cells has been reported in numerous experiments (8,10), in
agreement with the results of our model. A seemingly
surprising result borne out by the model is the role of stim-
ulatory receptors in inducing inhibition when the ligand
affinity is weak. This could be important in explaining
how knocking out the adaptor DAP12 that enables signal
propagation via certain stimulatory NK receptors results in
an enhanced NK cell activation (18).
We also found the counterintuitive result that under
certain conditions, such as the presence of weak-affinity
stimulatory ligands and limiting concentrations of the phos-
phatase SHP-1 (19,20), inhibitory receptors can help in
mediating activation. Recently, interactions between inhibi-
tory receptors and their cognate ligands (MHC class I mole-
cules) were found to play an important role in the
development of functional NK cells. The immature NK
cells, not subject to interactions with MHC class I mole-
cules, develop as hyporesponsive, nonfunctional mature
cells (5,6). There are speculations and experimental evid-
ence about the participation of inhibitory receptors in activa-
tion during the development of these cells (9,21,22). The
results from our simulation suggest a mechanism used by
inhibitory receptors under certain circumstances to induce
activation in general.
Cross talk between dueling signaling pathways is com-
monly encountered in signaling processes in other types ofcells (23,24), as, for example, Toll-like receptor signaling
in macrophages (24,25) and programmed-death (PD)
receptor signaling in T-cells (26), which are important
players in our immune system. Seemingly nonintuitive
results, where stimulatory receptors help mediate inhibition
or inhibitory receptors induce activation, have been reported
in experiments in those signaling networks also (27). Thus,
the system-level understanding gained from this study with
NK cells can help in understanding signaling kinetics and
cell activation in those systems as well. To the best of our
knowledge, this is the first attempt to uncover mechanistic
principles underlying NK-cell activation and tolerance at
the molecular level using a computational approach.MODEL
We have constructed a computational model based on the
signaling pathway shown in Fig. 1. In the model, stimulatory
receptors are associated with immunoreceptor-based tyro-
sine activation motif (ITAM) YxxL/Ix6–8YxxL/I, where x
is any amino acid (28), and inhibitory receptors with immu-
noreceptor-based tyrosine-inihibition motif (ITIM) V/I/
LxYxxL/V, where x is any amino acid (29). We specifically
modeled stimulatory receptors in mice, such as CD16 (8),
NKp46 (30,31), and Ly49D (32), in conjunction with mouse
inhibitory receptor Ly49A. The tyrosine residues (Y) in
ITAM and ITIM motifs, when phosphorylated by the Src
protein tyrosine kinases Lck or Fyn (33,34), initiate down-
stream signaling reactions. Each ITAMmotif can be in either
a partially or fully phosphorylated state (28), whereas an
ITIM motif can be fully activated or nonactivated (29,35).
Receptors in NK cells are associated with multiple ITAM
and ITIM motifs via different adaptor molecules, resulting
in a large number of possible activation states for those recep-
tors. In the model, we coarse-grain the multiple states of acti-
vation into a smaller set. For example, stimulatory receptors
can be in two different states of activation, namely, a partially
or a fully activated state, and inhibitory receptors can be in
either an activated or a nonactivated form. Thus, coarse-
grained fully and partially activated states of stimulatory
receptors can represent one or more fully phosphorylated
ITAMs and multiple partially phosphorylated ITAMs,
respectively, whereas coarse-grained activated and deacti-
vated states of inhibitory receptors represent two or more
phosphorylated ITIMs and fewer than two phosphorylated
ITIMs, respectively. This coarse-graining retains the essen-
tial activation states required for downstream signal propaga-
tion. Coarse-graining helps to keep the number of reactions
and species in the model within a computationally feasible
limit, which otherwise would increase prohibitively because
of the enormity of the combinatorial complexity associated
with a large number of activation states.
Basally active (dephosphorylated at Y505) and fully
activated (phosphorylated at Y394) forms of the Lck/Fyn
































FIGURE 1 Signaling network used in the model. The Src kinase Lck/Fyn activates the coarse-grained ITAMs and ITIMs associated with the stimulatory
(NKp46, CD16, or Ly49D) and inhibitory receptors (Ly49A), respectively. The above figure shows activation of coarse-grained ITAMs (dark rectangles) and
ITIMs (dark thick lines) representing more than one motif attached with a single receptor, receptor homodimers, or receptor clusters (see text for more
details). Heparin/IgG and H-2Dd are used as stimulatory and inhibitory ligands, respectively. Lck/Fyn can be in a basally activated (dark triangles) or a fully
activated state (light triangle). Activated states are indicated by small circles with a symbol P at the center. E.g., partially and fully activated states shown by
one and two such circles, respectively. Phosphatases deactivate the phosphorylated ITAMs and ITIMs. Fully activated stimulatory receptors recruit Zap70/
Syk molecules (lighter large circles), and receptor-bound Zap70/Syk become phosphorylated by the action of Src kinases (Lck/Fyn). Partially and fully acti-
vated stimulatory receptors and activated inhibitory receptors recruit SHP-1 molecules (ovals). Receptor-bound SHP-1 molecules can transition between
activated and basal states by the action of kinases and phosphatases. Vav molecules (hexagons) are activated and deactivated by activated Zap70/Syk and
receptor-bound SHP-1 molecules, respectively. However, only ITIM-bound SHP-1 has been found to deactivate Vav in experiments (48), and deactivation
of Vav by ITAM-bound SHP-1 molecules is assumed in the model. Activated Vav (pVav) phosphorylates Erk (pErk, darker large circles) in a coarse-grained
single reaction step (see text for details). Different phosphatase molecules deactivate both pVav and pErk.
2030 Dascatalytic rates (8,36). Fully activated Lck/Fyn activates
ITAMs/ITIMs with a much faster catalytic rate than basally
activated Lck/Fyn. In NK cells, the transition of Lck
between two different activated states and the nonactivated
state is coordinated by phosphatases such as CD45 and by
autophosphorylation (37,38). Phosphatases create basally
activated molecules from deactivated Lck/Fyn, and the
basally activated Lck/Fyn then autophosphorylates into the
fully phosphorylated form. In the model, Lck/Fyn can be
in two different activated states, namely, basally activated
(dephosphorylated at Y505) and fully activated (phosphory-
lated at Y394), and both the activation and deactivation of
Lck/Fyn are modeled as a first-order reaction process
without explicit consideration of the phosphatases. These
approximations are also made to keep the model computa-
tionally feasible.
After phosphorylation by the Src kinases, protein tyrosine
kinases, such as Zap70 and Syk, and protein tyrosine phos-
phatases, such as SHP-1, bind to phosphorylated tyrosine
residues associated with the receptors using tandem SH2
domains. Biochemical evidence suggests that fully activated
ITAMs recruit Zap70/Syk (39) or SHP-1 molecules,Biophysical Journal 99(7) 2028–2037whereas a partially phosphorylated ITAM binds to these
kinase and phosphatase molecules with an ~1000-fold-
lower affinity (40,41). A pair of fully phosphorylated ITIMs
placed either in tandem on a single inhibitory receptor mole-
cule or in parallel in receptor homodimers (such as the Ly49
family) recruits the phosphatase SHP-1 (29,35,41) but does
not bind to the kinases Zap70 or Syk. However, certain
ITAMs bound to adaptors (such as DAP12) associated
with stimulatory NK receptors possess a consensus ITIM
in the structure (27). This gives rise to the possibility that
SHP-1 molecules will bind in trans with a pair of partially
phosphorylated ITAMs with a strong affinity (27). In addi-
tion, unstable clusters of partially phosphorylated ITAMs
in receptors such as FcaRI have been assumed to recruit
SHP-1 efficiently, which raises the possibility of weakly
segregated clusters of ITAMs binding to SHP-1 molecules
with a higher affinity (42). In the model, we address these
issues in the following way. Fully phosphorylated states of
stimulatory receptors bind both Zap70/Syk and SHP-1
with similar affinities, and partially phosphorylated states
of these receptors bind only to SHP-1 with an affinity that
we have varied from a high value (as strong as the affinity
NK Cell Activation 2031of Zap70 binding to a doubly phosphorylated ITAM) to
a 1000-fold-lower value. Fully phosphorylated states of
inhibitory receptors bind to SHP-1 with as strong an affinity
as that of SHP-1 binding to fully activated stimulatory
receptors, and they do not recruit Zap70/Syk. There are
phosphatases that deactivate both ITAMs and ITIMs, but
as long as Zap70/Syk or SHP-1 molecules are bound to
the phosphorylated tyrosines of the ITAMs and ITIMs, those
residues are protected from the action of phosphatases.
Zap70/Syk kinases are activated by Lck/Fyn, and various
kinases activate SHP-1.
Activated Syk kinases (pZap70/pSyk) phosphorylate Vav,
a guanosine nucleotide exchange factor for the Rac family
of guanosine triphosphate (GTP) binding proteins (43,44).
Rac proteins, activated by phosphorylated Vav (pVav) mole-
cules, help NK cells mediate target-cell lysis by regulating
cytoskeletal alterations (43) and activating members of the
MAP kinase signaling pathway (17,43). The phosphatase,
SHP-1, can carry out its activity as a phosphatase as long
as it is bound to receptors (19,20). Activation of the catalytic
site of SHP-1 increases its dephosphorylation activity
approximately eightfold (19,45–47). Experiments show
that the only substrate associated with the catalytic site of
SHP-1 in NK cells is Vav1 (48). In other cell types, such
as T cells, SHP-1 has been found to deactivate substrates
such as pZap70/pSyk (45), phosphorylated ITAMs (45), or
Lck (49). We have used phosphorylated Vav as the only
substrate of SHP-1 which is consistent with current experi-
mental findings. However, we do a sensitivity analysis
(Fig. S7 and Fig. S8 in the Supporting Material) of the
results when SHP-1 can act on pLck, pZap70/pSyk, and
activated stimulatory receptors, in addition to pVav.
We have implemented a strict kinetic proofreading
scheme in the model in which an event of ligand unbinding
from a receptor leads to immediate dissociation of the mole-
cules attached to the receptor complex (50,51). This allows
the coarse-grained model to discriminate between strong-
and weak-affinity ligands in a realistic range of affinities.
Relaxing the strict kinetic proofreading scheme does not
produce a qualitative change in the results (Fig. S9 and
Fig. S10), but it leads to unrealistic activation of the system
by weak-affinity ligands. This difference is likely due to the
coarse-grained nature of the signaling model and does not
affect the mechanistic principles derived using the model.
A spatially inhomogeneous model that includes microscopic
clustering of membrane proximal signaling molecules con-
taining more details of molecular activation states will be
useful in addressing such differences between various
kinetic proofreading schemes.
Upon phosphorylation, Vav activates the extracellular-
signal-regulated kinase (Erk), an important mediator
of NK-cell cytotoxicity, following a Vav1/Rac1/
PAK1/MEK/Erk pathway in NK cells (8,17). The
signaling events from Vav to Erk activation are coarse-
grained in a single reaction step in the model, where pVavactivates Erk. Both Vav and Erk activations occur as
enzymatic reactions. Phosphatase molecules (52) (such as
MKP3) deactivate phosphorylated Erk. We use both pVav
and pErk as markers of NK-cell activation. The simplifica-
tions in the signaling network, noted above, are made
without sacrificing the essential details to make the compu-
tation feasible; even with these simplifications, there
are >690 reactions and >110 different species. The values
of the parameters, e.g., rate constants and species concentra-
tions, used in the model are shown in the Supporting Mate-
rial. Some of the rate constants and concentrations have
been measured in experiments, but many of the parameters
are unknown and we have estimated their values from
related models and their measured values in other cell types.
We also vary the parameters across a wide range to establish
the robustness of the reported results. Details of the sensi-
tivity analysis are given in the Supporting Material.METHODS
Stochastic simulation
We solve the master equation (15) associated with the reactions demon-
strated in the signaling network shown in Fig. 1. The master equation
describes the intrinsically stochastic kinetics of a system undergoing
changes after a set of chemical reactions. A recently developed stochastic
simulator compiler (SSC) (53) is used to solve the master equation exactly
using the standard Gillespie algorithm (53). In the simulation, molecules of
different species, distributed homogeneously in space, interact after the
reactions shown in Table S1. The rate constants and the initial concentra-
tions are given in the first six tables in the Supporting Material.RESULTS
NK-cell activation is digital in nature
We used ITAM-associated stimulatory receptor NKp46 and
its high-affinity (koff ~ 0.003 s
1 (54)) cognate ligand
(heparin) to study the nature of NK-cell activation as the
concentration of the stimulatory ligand is increased. Inhibi-
tory receptor Ly49A and its ligand H-2Dd (koff ~ 0.025 s
1
(55)) initiate signaling in the inhibitory arm of the signaling
network in the simulation. As the concentration of the stim-
ulatory ligand is increased beyond a threshold, the activa-
tion, measured as the amount of activated Vav (pVav)
produced by a cell population (Fig. 2 A), increases substan-
tially. The concentration of activated Erk molecules (pErk),
regulated by pVav, behaves in a similar manner (Fig. 2 B).
The threshold for activation increased as the concentration
of inhibitory ligands increased. The activation profiles
shown in Fig. 2, A and B, collapse (insets) into a single curve
when the concentrations of pVav and pErk are varied with
respect to the ratio (R) of the concentrations of activated
Zap70/Syk and receptor-bound SHP-1 molecules. This
demonstrates that the threshold of NK-cell activation
crucially depends on the ratio, R. The values of the concen-
trations of phosphorylated Zap70/Syk and receptor bound
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FIGURE 2 Digital activation of Vav and Erk in simulation. (A) Variation of pVav with increase in number of stimulatory ligands in a cell population of
4000 cells, where cells are presented with 200 (circles), 300 (squares), and 400 (triangles) inhibitory ligand. pVav concentrations are measured 10 min after
the stimulation. (Inset) Scaling of the data in the main figure when varied with respect to R, the ratio of pZap70/pSyk to receptor-bound SHP-1 molecules. (B)
Erk activation for the same set of parameters as in A, with different concentrations of inhibitory ligand shown by the same symbols as in A. (Inset) Scaling of
the data. (C) Distribution of pVav at different times in a cell population of 4000 cells for 270, 350, and 500 copy numbers of stimulatory ligands. The number
of inhibitory ligands is set to 200 for all the cases shown here. (D) Distribution of pErk molecules, with parameters as in C. Note the persistent and transient
bimodal distributions at 270 and 500 inhibitory ligands, respectively. The bimodal nature of Erk activation does not change qualitatively in the presence of
extrinsic noise (Fig. S4). See Table S1 and Table S2 for values of the parameters used.
2032 Dasactivated; the larger the concentrations, the faster the
dynamics (Fig. S3). The results shown in Fig. 2, A and B,
remain qualitatively similar when most of the parameters
in the model are varied. For example, we tested how the
reduction of the affinity (up to 1000 times) of SHP-1 binding
to partially phohsphorylated ITAMs, as observed in in vitro
experiments, affects the results in Fig. 2. Our results show
that the qualitative nature of digital activation does not
change with the variation (Fig. S11), but the activation
threshold shifts to a lower concentration of stimulatory
ligands as the affinity is reduced. The details of the sensi-
tivity of the results to variation of the other parameters are
given in the Table S9 and Table S10).
The origin of an activation threshold in the Vav activation
profile arises due to the competitive nature of enzymatic acti-
vation and deactivation of Vav molecules mediated by
phosphorylated Zap70/Syk and receptor-bound SHP-1mole-
cules, respectively. Such a competition can result in a sharp
activation, especially when the relative concentrations ofBiophysical Journal 99(7) 2028–2037the enzymes are much lower than those of the substrates.
Furthermore, the ratio (R) of the concentrations of the
enzymes mediating activation and deactivation plays a deci-
sive role in producing activation in the system (see details in
Section B of the SupportingMaterial). The sharp response of
the system to changing enzyme concentrations is known as
zeroth-order ultrasensitivity (56). Increasing the concentra-
tion of stimulatory ligands in the system causes production
of a greater number of completely phosphorylated receptors
than partially phosphorylated receptors due to the strong
affinity of the ligands. This results in recruitment of more
Zap70/Syk than SHP-1 molecules to the stimulatory recep-
tors, which increases the ratio (R) of activated Zap70/Syk
concentrations to receptor-bound SHP-1 molecules (Fig. S3
C), leading to a robust Vav activation as the ratio increases
beyond a threshold (Fig. 2 A). The sharp Vav activation gives
rise to a digital Erk activation (Fig. 2 B). The scaling in the
activation profiles of Vav and Erk in Fig. 2, A and B, results
from the regulation of activation of a substrate (pVav) by
NK Cell Activation 2033two opposing enzymes. However, this scaling is strictly valid
when Michaelis-Menten approximations hold for the enzy-
matic processes. This point is elaborated in the Section B
of the Supporting Material.
Stochastic fluctuations in copy numbers of signaling
molecules, which arise from the intrinsic random nature of
biochemical reactions, can significantly affect the activation
of NK cells at the single-cell level (see Fig. 2, C and D).
At concentrations of stimulatory ligands close to the
threshold of Vav activation (~250 stimulatory ligands),
pVav (Fig. 2 C) and pErk (Fig. 2 D) at the single-cell level
are distributed with a wide range and a bimodal distribution,
respectively. The bimodal distributions indicate how stoc-
hastic fluctuations are capable of producing binary out-
comes (activated or deactivated) at the single-cell level,
even in the absence of any positive feedback. Usually, posi-
tive feedback in signaling networks is implicated in such
behavior, but such is not the case in the signaling network
studied here. The bimodality in Erk activation persists
(Fig. S4) even when the different protein levels vary due
to extrinsic noise fluctuations. The bimodality in the distri-
bution of levels of pErk originates from the copy number
fluctuations of the pVav molecules that activate Erk in the
model. Such number fluctuations in enzymes in enzymatic
futile cycles are capable of producing a bimodal response
in activated molecules (57,58). For larger concentrations
of stimulatory ligands, the kinetics of Vav and Erk activation
becomes faster, and the cell population shows unimodal
distributions in Vav and Erk activation (Fig. 2, C and D)
at later times. However, the cells may transit through
a bimodal distribution in Erk activation as they move from
a resting state to an activated state (Fig. 2 D).Weak-affinity stimulatory ligands can mediate
inhibition
We include a mixture of weak- and strong-affinity stimula-
tory ligands cognate to two different types of stimulatoryare present (open circles) than when they are absent, as for NK cells in DAP1
and receptor-bound SHP-1 as the concentration of weak-affinity stimulatory ligan
in the presence of weak-affinity stimulatory receptors. See Table S3 and Tablereceptors in NK cells in the simulation. The inhibitory
receptor (Ly49A) also interacts with the weak stimulatory
ligands. This situation can occur in NK cells where the
inhibitory receptor, Ly49A, and the stimulatory receptor,
Ly29D, bind to the same ligand, H-2Dd. The stimulatory
receptor, Ly49D, is associated with the adaptor DAP12,
which contains two ITAM motifs and binds to the ligand
H-2Dd with a weak affinity (18). The result of this simula-
tion is shown in Fig. 3 A, where stimulatory ITAM-associ-
ated CD16 and Ly29D receptors are presented with
antibodies (IgG) and H-2Dd, respectively. As the concentra-
tion of the weaker-affinity stimulatory ligand (H-2Dd) is
increased, Vav and Erk activation are decreased. However,
a similar increase in the concentration of the weak stimula-
tory ligand (H-2Dd) does not result in a large decrease of
Vav and Erk activation when the stimulatory receptor
(Ly49D) that binds the weaker stimulatory ligands is absent.
The latter case represents NK cells in DAP12 knockout
mice. The results described above can be understood in
the following way. Since the weaker ligands bind stimula-
tory receptors (Ly49D) with a shorter half-life, they produce
more partially phosphorylated receptors than fully phos-
phorylated receptors (Fig. 3 B). The partially phosphory-
lated receptors recruit the phosphatase SHP-1.
Consequently, increasing the number of such weak-affinity
stimulatory ligands would increase the concentration of
SHP-1 molecules, strengthening the inhibitory arm of the
membrane proximal signaling. Therefore, when NK cells
are presented with a mixture of strong- and weak-affinity
stimulatory ligands, increasing the concentration of the
weak-affinity stimulatory ligands would favor inhibition
instead of activation, although the weak stimulatory ligands
initiate signaling through the ITAM-associated receptors.
The results in Fig. 3 A may provide a mechanistic frame-
work underlying the seemingly unexpected results reported
in Takaki et al. (18) regarding the activation of NK cells in
DAP12 knockout mice. In the experiments, DAP12-defi-
cient NK cells killed target cells (P815) coated withFIGURE 3 Weak-affinity stimulatory ligands
mediate inhibition. NK cells are presented with
a mixture of weak-affinity (H-2Dd, koff ~ 0.8 s
1)
and strong-affinity (IgG, koff ~ 0.0047 s
1) stimu-
latory ligands. The weak-affinity ligand also
interacts with the inhibitory receptors (Ly49A,
koff ~ 0.025 s
1). The cells are presented with
150 strong-affinity stimulatory ligands and the
concentration of the weaker-affinity ligand is
increased. The activation marker molecules
(pVav and pErk) are shown at t ¼ 10 min in
a cell population of 4000 in silico cells. (A)
Decrease of Vav and Erk (inset) activation as the
number of weak-affinity stimulatory ligands is
increased. The decrease in activation is larger
when the weaker-affinity stimulatory receptors
2-knockout mice (solid circles). (B) Variation in numbers of pZap70/pSyk
ds is increased. Note the larger increase in receptor-bound SHP-1 molecules
S4 for the values of the parameters used.
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2034 Dasantibodies (cognate ligands of CD16) with a higher effi-
ciency than wild-type cells. The target cells, in addition to
expressing ligands to the receptor CD16, also present
H-2Dd ligands to the NK cells. The H-2Dd ligands interact
with the inhibitory Ly49A receptors and the weak-affinity
stimulatory receptor, Ly49D. Thus, the higher activation
in DAP12-knockout NK cells may result from the lack of
efficient recruitment of SHP-1 molecules in the NK cells,
as the stimulatory receptors interacting with the weaker-
affinity ligands (H-2Dd) in the system are unable to recruit
SHP-1 in the absence of the adaptor DAP12.Inhibitors as activators
We present a scenario in which increasing the concentration
of inhibitory ligands increases Vav and Erk activation
(Fig. 4 A). This situation arises when NK cells are presented
with weaker-affinity stimulatory ligands (koff ¼ 0.3 s1) in
the presence of a low SHP-1 concentration, which is required
to be much smaller than the concentration of both the
(partially and fully) phosphorylated stimulatory receptors
and Zap70 molecules. This effect also requires that SHP-1
molecules bind to partially phosphorylated stimulatory
receptors and activated inhibitory receptors with comparable
affinity (Fig. S12). As discussed previously, this is more
likely to occur when stimulatory receptors are associated
with DAP12 adaptors. The counterintuitive result shown in
Fig. 4 can be understood mechanistically in the following
way. In the presence of weak-affinity stimulatory ligands,
a majority of the stimulatory receptors are partially phos-
phorylated, and these receptors recruit most of the avail-
able SHP-1 molecules. The few fully phosphorylated
stimulatory receptors bind to Zap70/Syk molecules. Since
Vav activation is determined by R ¼ number of pZap70=
pSyk=number of SHP-1 bound to receptors, and the num-
ber of pZap70/pSyk is much smaller than that of the
receptor-bound SHP-1 molecules, this does not lead to acti-Variations in numbers of fully and partially activated stimulatory receptors, pZap
itory ligands. (B) Comparison of Vav activation for two different inhibitory ligan
pair is decreased. In one case, no inhibitory ligand is present, and in the other c
stimulatory ligand affinities for which inhibitory ligands promote activation. (I
Table S5 and Table S6 for values of the parameters used.
Biophysical Journal 99(7) 2028–2037vation, even in the absence of inhibitory ligands (Fig. 4 A,
right inset). However, when strong-affinity inhibitory ligands
are present in excess, the large number of activated inhibitory
receptors act as strong recruiters for the SHP-1 molecules.
In this situation, SHP-1 molecules leave the partially phos-
phorylated stimulatory receptors to become associated with
the activated inhibitory receptors. Thus, the total number of
receptor-bound SHP-1 molecules does not change appre-
ciably in this process, as the SHP-1 molecules effectively
change their association from the partially phosphorylated
stimulatory receptors to the phosphorylated inhibitory recep-
tors (Fig. 4 A, right inset). This leaves the partially phos-
phorylated stimulatory receptors, unattached to any SHP-1
molecules, available to become fully phosphorylated and
recruit Zap70/Syk. This increases the number of Zap70/
Sykmolecules bound to the fully phosphorylated stimulatory
receptors, thereby increasing the concentration of activated
Zap70/Sykmolecules (Fig. 4A, right inset) and consequently
increasing R (Fig. 4 A, left inset). When the magnitude of R
becomes sufficiently large, it produces a robust Vav and an
ensuing Erk activation. The series of signaling events that
lead to this behavior is shown in a set of cartoons in
Fig. S13.We also studied how the binding affinity of the stim-
ulatory receptor ligand regulates this effect. The results
shown in Fig. 4 B demonstrate that stimulatory ligands
with a range of affinities can help mediate activation via
inhibitory receptors. This range depends on various parame-
ters, such as SHP-1 concentration or Vav activation rate.
We also found that the effect of activation promoted by inhib-
itory receptors does not change qualitatively if the SHP-1 is
allowed to act on other substrates, such as activated Zap70/
Syk, activated stimulatory receptors, or Lck molecules, in
addition to Vav1 (Fig. S8). In addition, relaxing the strict
kinetic proofreading condition in the model does not change
the qualitative nature of this behavior (Fig. S10). We per-
formed a detailed sensitivity analysis of the results shown
in Fig. 4, the details of which are presented in Table S11FIGURE 4 Inhibitory ligands promote activation.
NK cells are presented with a combination
of moderately-weak-affinity stimulatory ligands
(koff ¼ 0.4 s1) and strong-affinity inhibitory
ligands (koff ¼ 0.025 s1). The number of stimula-
tory ligands is kept fixed at 150 as the number of
inhibitory ligands is increased. SHP-1 is limited in
the system and the concentration is 2.6% of the
SHP-1 level in the wild-type cells in the simulation.
All concentrations were measured at 10 min after
stimulation in a cell population of 4000 cells. (A)
Variations of pVav (circles) and pErk (squares)
with increasing concentration of inhibitory ligands.
(Left inset) Increase in ratio, R, with increase in
concentration of inhibitory ligands. (Right inset)
70/pSyk, and receptor-bound SHP-1 with increasing concentration of inhib-
d concentrations as the half-life (~1/koff)) of the stimulatory receptor ligand
ase, 1000 inhibitory ligands are present. The dotted lines show the range of
nset) Corresponding Erk activation for the two ligand concentrations. See
NK Cell Activation 2035and Table S12).We also construct a minimal model to under-
stand general mechanisms underlying the results in the
previous section. The model consists of a set of essential
signaling events required to capture the competition between
stimulatory and inhibitory pathways that lead to Vav activa-
tion. The details of the model are shown in Section C of the
Supporting Material. From the minimal model, it can be
seen that the conditions required to achieve activation
through inhibitory receptors are 1), a weak-affinity stimula-
tory ligand; 2), a small number of SHP-1 molecules, where
the range is determined by the numbers of stimulatory and
inhibitory receptor-ligand complexes; 3), strong-affinity
binding of SHP-1 to partially activated stimulatory receptors;
and 4), an excess number of Zap70/Syk molecules.DISCUSSION
We have constructed a detailed molecular model that incor-
porates membrane-proximal signaling events in NK cells.
The model provides mechanistic understanding about how
the strength of binding between stimulatory receptors and
their cognate ligands regulates activation of downstream
products of the signaling network leading to NK cell activa-
tion. We show that the strength of the stimulatory and inhib-
itory signals characterized by the concentrations of
phosphorylated Zap70/Syk molecules and receptor-bound
SHP-1 molecules, respectively, regulate activation of Vav,
a marker for NK-cell activation. The magnitude of the
concentrations of phosphorylated Zap70/Syk and receptor-
bound SHP-1 molecules determines how fast Vav is acti-
vated or deactivated, whereas the ratio of the concentrations
of Zap70/Syk to receptor-bound SHP-1 molecules deter-
mines whether Vav is activated robustly. We demonstrate
that Vav activation, and consequently Erk activation, is
digital in nature. The sharp response of Vav activation arises
from the competing enzymatic activation and deactivation
of Vav molecules. We also demonstrate that stochastic fluc-
tuations in copy number are capable of producing binary (all
or none) Erk activation at the single-cell level even in the
absence of any positive feedback.
We show that weak-affinity stimulatory ligands generate
more partially activated stimulatory receptors than fully
activated receptors. These partially activated stimulatory
receptors recruit more phosphatase (SHP-1) molecules
compared to the kinase (Zap70/Syk) molecules contributing
toward Vav deactivation. In addition to the weak affinity of
DAP12-associated stimulatory Ly49 receptors in mice for
H-2dd ligands, DAP12-bound stimulatory KIR receptors in
human NK cells show weak affinity toward cognate ligands
(HLA) (59); therefore, these NK receptors can mediate inhi-
bition instead of activation. Similar mechanisms where inhi-
bition is mediated by ITAM-associated receptors binding
to low-affinity ligands exist in various other signaling
networks (27,34,60). A closely related example is inhibition
of activation in T-lymphocytes in the presence of weaker-affinity antagonist ligands (45). In myeloid cells, low-
affinity cognate ligands partially phosphorylate the ITAMs
associated with FcR receptors, recruiting more SHP-1 mole-
cules to the plasma membrane, which deactivate the Toll-
like receptor signaling intermediates and induce inhibition
(25). Therefore, the general mechanistic principles respon-
sible for NK-cell inhibition in the presence of low-affinity
stimulatory ligands could be applicable to such signaling
networks as well. It has been found that sequestration of
receptor-activating kinases by clusters of low-affinity stim-
ulatory ligands is responsible for mediating inhibition in
mast cells (61). It will be interesting to investigate the impli-
cations of similar mechanisms in NK-cell signaling.
A counterintuitive result borne out from my modeling is
the induction of activation mediated indirectly through the
inhibitory receptors. This occurs under a specific set of
conditions: 1), the presence of weak-affinity stimulatory
ligands; 2), limited concentrations of SHP-1; 3), high-
affinity binding of SHP-1 to partially activated stimulatory
receptors; and 4), excess Zap70/Syk. The series of events
that lead to this effect are shown in Fig. S13. When the
above conditions are met, increasing the concentration of
inhibitory ligands leads to Vav activation. Similar mecha-
nisms may underlie the puzzling result, reported by Tai
et al. (62), that ITIM-associated Ly49Q receptors enhance
activation in plasmacytoid dendritic cells (pDC) in vitro as
a response to Toll-like receptor 9 agonist CpG oligonucleo-
tide. Recently, it was found that interactions between
inhibitory receptors and MHC class I molecules play an
important role in the development of functional NK cells.
Immature NK cells, not subject to interactions with the
MHC class I molecules, develop as hyporesponsive
nonfunctional mature cells (5,6). There are speculations
and experimental evidence about the participation of inhib-
itory receptors in activation during the development of these
cells (9,21,22). The results from my simulation may provide
a novel mechanism by which inhibitory receptors under
certain circumstances induce activation.
Themodel does not encompass all the complexities inNK-
cell signaling. For example, stimulatory receptors such as
NKG2D-L in mice (NKG2D in human) are not incorporated
in the model. These receptors are associated with the adaptor
DAP10, which carries a YXXMmotif (where X is any amino
acid), instead of ITAMs, and they mediate Erk activation
through PI3K. Furthermore, unlike T-cells, many members
of the Src and Syk kinase family can function redundantly
in NK-cell activation. NK cells develop and kill target cells
normally in Lck//Fyn/ (63) or Syk//Zap70/ (64)
double-knockout mice. This could imply that there are
more Src and Syk kinases in NK cells, in addition to Lck,
Fyn, or Zap70/Syk, as well as redundant pathways (64)
involving other signaling molecules. Many details of such
multiplicity in signaling pathways still remain unclear, and
extending the model to study the implications of such multi-
plicities in enzymes and pathways could be very useful inBiophysical Journal 99(7) 2028–2037
2036 Dasunderstanding the experimental results. Also, in the model
presented here, the kinases Zap70 and Syk are treated
equally. However, biochemical studies suggest, Zap70 and
Syk can bind to partially phosphorylaed ITAMs, and unlike
Zap70, Syk can phosphorylate ITAMs (65). It has been
observed that Dectin-1, an NK receptor, activates Syk in
macrophages with an associated single-modified ITAM-
like YXXL motif (66). Furthermore, it has been observed
that various membrane-proximal signaling events, such as
signaling through adhesion receptors (67), synergy between
different NK receptors (68), or regulation of Src kinases by
transmembrane phosphatases (37), influence NK-cell activa-
tion. These molecular details may have important implica-
tions regarding the mechanisms underlying NK-cell
activation, and we plan to incorporate them into my compu-
tational model in the future. In addition, the model is inca-
pable of describing later time events involving spatial
segregation of signaling molecules, such as selective clus-
tering of receptors, ligands, and various signaling molecules
on the plasma membrane (69) and cytoskeletal remodeling
(67), which may significantly contribute to hierarchical
signal propagation, leading to NK-cell activation. A spatially
inhomogeneous modeling (53,70) of the signaling kinetics
that incorporates detailed molecular activation states, micro-
scopic spatial clustering, and diffusion and transport of
different species can provide important mechanistic insights
into such processes.SUPPORTING MATERIAL
Tables, figures, references, and equations are available at http://www.
biophysj.org/biophysj/supplemental/S0006-3495(10)00935-5.
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